Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 650 entries
Sorted by: Best Match Show Resources per page
Effects of Benzodiazepines on Acinar and Myoepithelial Cells.

Frontiers in pharmacology

Mattioli TM, Alanis LR, Sapelli Sda S, de Lima AA, de Noronha L, Rosa EA, Althobaiti YS, Almalki AH, Sari Y, Ignacio SA, Johann AC, Gregio AM.
PMID: 27445812
Front Pharmacol. 2016 Jun 24;7:173. doi: 10.3389/fphar.2016.00173. eCollection 2016.

BACKGROUND: Benzodiazepines (BZDs), the most commonly prescribed psychotropic drugs with anxiolytic action, may cause hyposalivation. It has been previously shown that BZDs can cause hypertrophy and decrease the acini cell number. In this study, we investigated the effects of...

Cite
Mattioli TM, Alanis LR, Sapelli Sda S, et al. Effects of Benzodiazepines on Acinar and Myoepithelial Cells. Front Pharmacol. 2016;7:173doi: 10.3389/fphar.2016.00173.
Mattioli, T. M., Alanis, L. R., Sapelli, S. d. a. . S., de Lima, A. A., de Noronha, L., Rosa, E. A., Althobaiti, Y. S., Almalki, A. H., Sari, Y., Ignacio, S. A., Johann, A. C., & Gregio, A. M. (2016). Effects of Benzodiazepines on Acinar and Myoepithelial Cells. Frontiers in pharmacology, 7173. https://doi.org/10.3389/fphar.2016.00173
Mattioli, Tatiana M F, et al. "Effects of Benzodiazepines on Acinar and Myoepithelial Cells." Frontiers in pharmacology vol. 7 (2016): 173. doi: https://doi.org/10.3389/fphar.2016.00173
Mattioli TM, Alanis LR, Sapelli Sda S, de Lima AA, de Noronha L, Rosa EA, Althobaiti YS, Almalki AH, Sari Y, Ignacio SA, Johann AC, Gregio AM. Effects of Benzodiazepines on Acinar and Myoepithelial Cells. Front Pharmacol. 2016 Jun 24;7:173. doi: 10.3389/fphar.2016.00173. eCollection 2016. PMID: 27445812; PMCID: PMC4919344.
Copy Download .nbib Format: NLM
The Fluoxetine and Suicide Controversy : A Review of the Evidence.

CNS drugs

Healy D.
PMID: 27520521
CNS Drugs. 1994 Mar;1(3):223-31. doi: 10.2165/00023210-199401030-00007.

Evidence is emerging that a range of psychotropic drugs may precipitate akathisia and/or panic reactions in predisposed patients. The use of fluoxetine has hitherto been the most notable example of this occurrence. These reactions may foster the genesis of...

Cite
Healy D. The Fluoxetine and Suicide Controversy : A Review of the Evidence. CNS Drugs. 1994;1(3):223-31doi: 10.2165/00023210-199401030-00007.
Healy, D. (1994). The Fluoxetine and Suicide Controversy : A Review of the Evidence. CNS drugs, 1(3), 223-31. https://doi.org/10.2165/00023210-199401030-00007
Healy, D. "The Fluoxetine and Suicide Controversy : A Review of the Evidence." CNS drugs vol. 1,3 (1994): 223-31. doi: https://doi.org/10.2165/00023210-199401030-00007
Healy D. The Fluoxetine and Suicide Controversy : A Review of the Evidence. CNS Drugs. 1994 Mar;1(3):223-31. doi: 10.2165/00023210-199401030-00007. PMID: 27520521.
Copy Download .nbib Format: NLM
Relapse Prevention in Alcoholism : Recent Advances and Future Possibilities.

CNS drugs

Soyka M.
PMID: 27520754
CNS Drugs. 1997 Apr;7(4):313-27. doi: 10.2165/00023210-199707040-00004.

Most psychotropic drugs, such as antipsychotics, lithium and tricyclic antidepressants, do not improve alcohol (ethanol) abstinence rates, at least in alcohol-dependent patients who do not have a comorbid psychiatric disorder. In recent years, numerous studies have been published that...

Cite
Soyka M. Relapse Prevention in Alcoholism : Recent Advances and Future Possibilities. CNS Drugs. 1997;7(4):313-27doi: 10.2165/00023210-199707040-00004.
Soyka, M. (1997). Relapse Prevention in Alcoholism : Recent Advances and Future Possibilities. CNS drugs, 7(4), 313-27. https://doi.org/10.2165/00023210-199707040-00004
Soyka, M. "Relapse Prevention in Alcoholism : Recent Advances and Future Possibilities." CNS drugs vol. 7,4 (1997): 313-27. doi: https://doi.org/10.2165/00023210-199707040-00004
Soyka M. Relapse Prevention in Alcoholism : Recent Advances and Future Possibilities. CNS Drugs. 1997 Apr;7(4):313-27. doi: 10.2165/00023210-199707040-00004. PMID: 27520754.
Copy Download .nbib Format: NLM
Metacognitive therapy (MCT+) in patients with psychosis not receiving antipsychotic medication: A case study.

Frontiers in psychology

Balzan RP, Galletly C.
PMID: 26217283
Front Psychol. 2015 Jul 09;6:967. doi: 10.3389/fpsyg.2015.00967. eCollection 2015.

BACKGROUND: Psychotherapies for psychosis typically aim to develop an awareness of the implausible content of a delusion or target the underlying cognitive biases (i.e., problematic thinking styles, such as hasty decisions and illusory control) that foster and maintain delusional...

Cite
Balzan RP, Galletly C. Metacognitive therapy (MCT+) in patients with psychosis not receiving antipsychotic medication: A case study. Front Psychol. 2015;6:967doi: 10.3389/fpsyg.2015.00967.
Balzan, R. P., & Galletly, C. (2015). Metacognitive therapy (MCT+) in patients with psychosis not receiving antipsychotic medication: A case study. Frontiers in psychology, 6967. https://doi.org/10.3389/fpsyg.2015.00967
Balzan, Ryan P, and Galletly, Cherrie. "Metacognitive therapy (MCT+) in patients with psychosis not receiving antipsychotic medication: A case study." Frontiers in psychology vol. 6 (2015): 967. doi: https://doi.org/10.3389/fpsyg.2015.00967
Balzan RP, Galletly C. Metacognitive therapy (MCT+) in patients with psychosis not receiving antipsychotic medication: A case study. Front Psychol. 2015 Jul 09;6:967. doi: 10.3389/fpsyg.2015.00967. eCollection 2015. PMID: 26217283; PMCID: PMC4496559.
Copy Download .nbib Format: NLM
Recurrent brief depression: A frequent syndrome in clinical practice.

International journal of psychiatry in clinical practice

Angst J, Kasper S, Weiller E.
PMID: 24927453
Int J Psychiatry Clin Pract. 2000;4(3):195-9. doi: 10.1080/13651500050518073.

Recurrent brief depression (RBD) is not a new artificial group of depression syndromes, but an important, frequently overlooked and clearly identified subcategory of depressive disorders. The symptoms do not differ from major depression; however, the duration of the brief...

Cite
Angst J, Kasper S, Weiller E. Recurrent brief depression: A frequent syndrome in clinical practice. Int J Psychiatry Clin Pract. 2000;4(3):195-9doi: 10.1080/13651500050518073.
Angst, J., Kasper, S., & Weiller, E. (2000). Recurrent brief depression: A frequent syndrome in clinical practice. International journal of psychiatry in clinical practice, 4(3), 195-9. https://doi.org/10.1080/13651500050518073
Angst, J, et al. "Recurrent brief depression: A frequent syndrome in clinical practice." International journal of psychiatry in clinical practice vol. 4,3 (2000): 195-9. doi: https://doi.org/10.1080/13651500050518073
Angst J, Kasper S, Weiller E. Recurrent brief depression: A frequent syndrome in clinical practice. Int J Psychiatry Clin Pract. 2000;4(3):195-9. doi: 10.1080/13651500050518073. PMID: 24927453.
Copy Download .nbib Format: NLM
Pharmacological treatment of Alzheimer disease: from psychotropic drugs and cholinesterase inhibitors to pharmacogenomics.

Drugs of today (Barcelona, Spain : 1998)

Cacabelos R, Alvarez A, Lombardi V, Fernández-Novoa L, Corzo L, Pérez P, Laredo M, Pichel V, Hernández A, Varela M, Figueroa J, Prous J, Windisch M, Vigo C.
PMID: 12861345
Drugs Today (Barc). 2000 Jul;36(7):415-99.

For the past 20 years the scientific community and the pharmaceutical industry have been searching for treatments to neutralize the devastating effects of Alzheimer disease (AD). During this period important changes in the etiopathogenic concept of AD have occurred...

Cite
Cacabelos R, Alvarez A, Lombardi V, et al. Pharmacological treatment of Alzheimer disease: from psychotropic drugs and cholinesterase inhibitors to pharmacogenomics. Drugs Today (Barc). 2000;36(7):415-99
Cacabelos, R., Alvarez, A., Lombardi, V., Fernández-Novoa, L., Corzo, L., Pérez, P., Laredo, M., Pichel, V., Hernández, A., Varela, M., Figueroa, J., Prous, J., Windisch, M., & Vigo, C. (2000). Pharmacological treatment of Alzheimer disease: from psychotropic drugs and cholinesterase inhibitors to pharmacogenomics. Drugs of today (Barcelona, Spain : 1998), 36(7), 415-99.
Cacabelos, R, et al. "Pharmacological treatment of Alzheimer disease: from psychotropic drugs and cholinesterase inhibitors to pharmacogenomics." Drugs of today (Barcelona, Spain : 1998) vol. 36,7 (2000): 415-99.
Cacabelos R, Alvarez A, Lombardi V, Fernández-Novoa L, Corzo L, Pérez P, Laredo M, Pichel V, Hernández A, Varela M, Figueroa J, Prous J, Windisch M, Vigo C. Pharmacological treatment of Alzheimer disease: from psychotropic drugs and cholinesterase inhibitors to pharmacogenomics. Drugs Today (Barc). 2000 Jul;36(7):415-99. PMID: 12861345.
Copy Download .nbib Format: NLM
[Psychiatric aspects of terrorism].

Anales de la Real Academia Nacional de Medicina

Alonso Fernández F.
PMID: 16773803
An R Acad Nac Med (Madr). 2002;119(4):579-94; discussion 594-7, 617-37.

The violence is systematized here in five types. The violence of terrorism is described as a modality of organized criminality elaborated for dominating other people in the field of politics, religion, economics or nationalism by means of terror. The...

Cite
Alonso Fernández F. Aspectos psiquiátricos del terrorismo. [Psychiatric aspects of terrorism]. An R Acad Nac Med (Madr). 2002;119(4):579-94; discussion 594-7, 617-37
Alonso Fernández, F. (2002). Aspectos psiquiátricos del terrorismo. [Psychiatric aspects of terrorism]. Anales de la Real Academia Nacional de Medicina, 119(4), 579-94; discussion 594-7, 617-37.
Alonso Fernández, Francisco. "Aspectos psiquiátricos del terrorismo." [Psychiatric aspects of terrorism]. Anales de la Real Academia Nacional de Medicina vol. 119,4 (2002): 579-94; discussion 594-7, 617-37.
Alonso Fernández F. Aspectos psiquiátricos del terrorismo. [Psychiatric aspects of terrorism]. An R Acad Nac Med (Madr). 2002;119(4):579-94; discussion 594-7, 617-37. Spanish. PMID: 16773803.
Copy Download .nbib Format: NLM
EEG mapping, psychometric, and polysomnographic studies in restless legs syndrome (RLS) and periodic limb movement disorder (PLMD) patients as compared with normal controls.

Sleep medicine

Saletu B, Anderer P, Saletu M, Hauer C, Lindeck-Pozza L, Saletu-Zyhlarz G.
PMID: 14592166
Sleep Med. 2002 Nov;3:S35-42. doi: 10.1016/s1389-9457(02)00147-8.

OBJECTIVES: Investigation of daytime brain function, psychopathology, and objective and subjective sleep and awakening quality in restless legs syndrome (RLS) and periodic limb movement disorder (PLMD).METHODS: Thirty-three RLS and 26 PLMD patients free of psychotropic drugs were studied as...

Cite
Saletu B, Anderer P, Saletu M, et al. EEG mapping, psychometric, and polysomnographic studies in restless legs syndrome (RLS) and periodic limb movement disorder (PLMD) patients as compared with normal controls. Sleep Med. 2002;3:S35-42doi: 10.1016/s1389-9457(02)00147-8.
Saletu, B., Anderer, P., Saletu, M., Hauer, C., Lindeck-Pozza, L., & Saletu-Zyhlarz, G. (2002). EEG mapping, psychometric, and polysomnographic studies in restless legs syndrome (RLS) and periodic limb movement disorder (PLMD) patients as compared with normal controls. Sleep medicine, 3S35-42. https://doi.org/10.1016/s1389-9457(02)00147-8
Saletu, B, et al. "EEG mapping, psychometric, and polysomnographic studies in restless legs syndrome (RLS) and periodic limb movement disorder (PLMD) patients as compared with normal controls." Sleep medicine vol. 3 (2002): S35-42. doi: https://doi.org/10.1016/s1389-9457(02)00147-8
Saletu B, Anderer P, Saletu M, Hauer C, Lindeck-Pozza L, Saletu-Zyhlarz G. EEG mapping, psychometric, and polysomnographic studies in restless legs syndrome (RLS) and periodic limb movement disorder (PLMD) patients as compared with normal controls. Sleep Med. 2002 Nov;3:S35-42. doi: 10.1016/s1389-9457(02)00147-8. PMID: 14592166.
Copy Download .nbib Format: NLM
The knowledge of inpatients with schizophrenia on their medication at hospital discharge.

Pharmacoepidemiology and drug safety

Dernovsek MZ, Bah B, Pintaric L, Tavcar R.
PMID: 19025836
Pharmacoepidemiol Drug Saf. 2000 Jul;9(4):327-33. doi: 10.1002/1099-1557(200007/08)9:4<327::AID-PDS504>3.0.CO;2-E.

Purpose-To examine the knowledge of schizophrenic in patients regarding their medication.Methods-Fifty male and 50 female patients with schizophrenia were interviewed before discharge from the University Psychiatric Hospital in Ljubljana, Slovenia. Socio-demographic and clinical data were collected and the Global...

Cite
Dernovsek MZ, Bah B, Pintaric L, et al. The knowledge of inpatients with schizophrenia on their medication at hospital discharge. Pharmacoepidemiol Drug Saf. 2000;9(4):327-33doi: 10.1002/1099-1557(200007/08)9:4<327::AID-PDS504>3.0.CO;2-E.
Dernovsek, M. Z., Bah, B., Pintaric, L., & Tavcar, R. (2000). The knowledge of inpatients with schizophrenia on their medication at hospital discharge. Pharmacoepidemiology and drug safety, 9(4), 327-33. https://doi.org/10.1002/1099-1557(200007/08)9:4<327::AID-PDS504>3.0.CO;2-E
Dernovsek, M Z, et al. "The knowledge of inpatients with schizophrenia on their medication at hospital discharge." Pharmacoepidemiology and drug safety vol. 9,4 (2000): 327-33. doi: https://doi.org/10.1002/1099-1557(200007/08)9:4<327::AID-PDS504>3.0.CO;2-E
Dernovsek MZ, Bah B, Pintaric L, Tavcar R. The knowledge of inpatients with schizophrenia on their medication at hospital discharge. Pharmacoepidemiol Drug Saf. 2000 Jul;9(4):327-33. doi: 10.1002/1099-1557(200007/08)9:4<327::AID-PDS504>3.0.CO;2-E. PMID: 19025836.
Copy Download .nbib Format: NLM
QT interval prolongation related to psychoactive drug treatment: a comparison of monotherapy versus polytherapy.

Annals of general psychiatry

Sala M, Vicentini A, Brambilla P, Montomoli C, Jogia JR, Caverzasi E, Bonzano A, Piccinelli M, Barale F, De Ferrari GM.
PMID: 15845138
Ann Gen Psychiatry. 2005 Jan 25;4(1):1. doi: 10.1186/1744-859X-4-1.

BACKGROUND: Several antipsychotic agents are known to prolong the QT interval in a dose dependent manner. Corrected QT interval (QTc) exceeding a threshold value of 450 ms may be associated with an increased risk of life threatening arrhythmias. Antipsychotic...

Cite
Sala M, Vicentini A, Brambilla P, et al. QT interval prolongation related to psychoactive drug treatment: a comparison of monotherapy versus polytherapy. Ann Gen Psychiatry. 2005;4(1):1doi: 10.1186/1744-859X-4-1.
Sala, M., Vicentini, A., Brambilla, P., Montomoli, C., Jogia, J. R., Caverzasi, E., Bonzano, A., Piccinelli, M., Barale, F., & De Ferrari, G. M. (2005). QT interval prolongation related to psychoactive drug treatment: a comparison of monotherapy versus polytherapy. Annals of general psychiatry, 4(1), 1. https://doi.org/10.1186/1744-859X-4-1
Sala, Michela, et al. "QT interval prolongation related to psychoactive drug treatment: a comparison of monotherapy versus polytherapy." Annals of general psychiatry vol. 4,1 (2005): 1. doi: https://doi.org/10.1186/1744-859X-4-1
Sala M, Vicentini A, Brambilla P, Montomoli C, Jogia JR, Caverzasi E, Bonzano A, Piccinelli M, Barale F, De Ferrari GM. QT interval prolongation related to psychoactive drug treatment: a comparison of monotherapy versus polytherapy. Ann Gen Psychiatry. 2005 Jan 25;4(1):1. doi: 10.1186/1744-859X-4-1. PMID: 15845138; PMCID: PMC1088007.
Copy Download .nbib Format: NLM
Fifty years chlorpromazine: a historical perspective.

Neuropsychiatric disease and treatment

Ban TA.
PMID: 19300578
Neuropsychiatr Dis Treat. 2007 Aug;3(4):495-500.

Chlorpromazine was synthesized in December 1951 in the laboratories of Rhône-Poiulenc, and became available on prescription in France in November 1952. Its effectiveness was reflected in the transformation of disturbed wards; its commercial success stimulated the development of other...

Cite
Ban TA. Fifty years chlorpromazine: a historical perspective. Neuropsychiatr Dis Treat. 2007;3(4):495-500
Ban, T. A. (2007). Fifty years chlorpromazine: a historical perspective. Neuropsychiatric disease and treatment, 3(4), 495-500.
Ban, Thomas A. "Fifty years chlorpromazine: a historical perspective." Neuropsychiatric disease and treatment vol. 3,4 (2007): 495-500.
Ban TA. Fifty years chlorpromazine: a historical perspective. Neuropsychiatr Dis Treat. 2007 Aug;3(4):495-500. PMID: 19300578; PMCID: PMC2655089.
Copy Download .nbib Format: NLM
Treatment of chronic pain with psychotropic drugs.

The Western journal of medicine

McAuley RA.
PMID: 18750644
West J Med. 1989 Sep;151(3):316.

No abstract available.

Cite
McAuley RA. Treatment of chronic pain with psychotropic drugs. West J Med. 1989;151(3):316
McAuley, R. A. (1989). Treatment of chronic pain with psychotropic drugs. The Western journal of medicine, 151(3), 316.
McAuley, R A. "Treatment of chronic pain with psychotropic drugs." The Western journal of medicine vol. 151,3 (1989): 316.
McAuley RA. Treatment of chronic pain with psychotropic drugs. West J Med. 1989 Sep;151(3):316. PMID: 18750644; PMCID: PMC1026874.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 650 entries